Compare ULTA & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ULTA | BNTX |
|---|---|---|
| Founded | 1990 | 2008 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.2B | 24.7B |
| IPO Year | 2007 | 2019 |
| Metric | ULTA | BNTX |
|---|---|---|
| Price | $536.82 | $96.92 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 28 | 20 |
| Target Price | ★ $630.64 | $117.14 |
| AVG Volume (30 Days) | 417.9K | ★ 710.1K |
| Earning Date | 08-27-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1.18 | N/A |
| EPS | ★ 14.31 | N/A |
| Revenue | ★ $12,392,820,000.00 | N/A |
| Revenue This Year | $7.12 | N/A |
| Revenue Next Year | $5.16 | $0.23 |
| P/E Ratio | $38.01 | ★ N/A |
| Revenue Growth | ★ 9.71 | N/A |
| 52 Week Low | $443.60 | $79.81 |
| 52 Week High | $714.97 | $124.00 |
| Indicator | ULTA | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 51.15 | 48.96 |
| Support Level | $529.01 | $87.31 |
| Resistance Level | $545.35 | $98.81 |
| Average True Range (ATR) | 13.13 | 2.78 |
| MACD | -1.44 | -0.09 |
| Stochastic Oscillator | 39.71 | 44.57 |
Ulta Beauty is the largest specialized beauty retailer in the US with more than 1,500 stores and e-commerce. The firm offers cosmetics (38% of 2025 sales), fragrances (13%), skin care (24%), and hair care products (19%). It also has salon services, including hair, makeup, skin, and brow, that account for 4% of its revenue and drive customer traffic. Outside of the US, Ulta operates premium beauty retailer Space NK (86 stores at year-end 2025 in the UK and Ireland), has franchised stores in Mexico, and a joint venture in the Middle East. Ulta was founded in 1990 and is based in Bolingbrook, Illinois.
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.